Search company, investor...

Founded Year

2002

Stage

Take Private | Alive

Total Raised

$28.41M

Valuation

$0000 

Revenue

$0000 

About Imprivata

Imprivata provides digital identity solutions for enterprises. It offers identity solutions, authentication solutions, access management solutions , and more. It serves industries such as healthcare, manufacturing, financial services, and more. It was founded in 2002 and is based in Waltham, Massachusetts.

Headquarters Location

20 CityPoint, 6th floor 480 Totten Pond Road

Waltham, Massachusetts, 02451,

United States

781-674-2700

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

ESPs containing Imprivata

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

EXECUTION STRENGTH ➡MARKET STRENGTH ➡LEADERHIGHFLIEROUTPERFORMERCHALLENGER
Enterprise Tech / Information Security

The identity & access management (IAM) market provides solutions for organizations to manage and secure user identities and access to resources, including applications, data, and systems. IAM solutions help organizations ensure that the right individuals have access to the right resources at the right time, while also protecting against unauthorized access and data breaches. The market includes a …

Imprivata named as Leader among 15 other companies, including WSO2, ForgeRock, and Rippling.

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo

Expert Collections containing Imprivata

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Imprivata is included in 3 Expert Collections, including Conference Exhibitors.

C

Conference Exhibitors

5,302 items

C

Cybersecurity

6,901 items

These companies protect organizations from digital threats.

D

Digital Health

10,563 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

Imprivata Patents

Imprivata has filed 48 patents.

The 3 most popular patent topics include:

  • Health informatics
  • Computer network security
  • Computer security
patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/7/2021

4/25/2023

Computer memory, Remote desktop, Thin clients, USB, Embedded operating systems

Grant

Application Date

1/7/2021

Grant Date

4/25/2023

Title

Related Topics

Computer memory, Remote desktop, Thin clients, USB, Embedded operating systems

Status

Grant

Latest Imprivata News

Zscaler Partners with Imprivata and CrowdStrike on new Zero Trust Security Solution for Healthcare Organisations

Sep 20, 2023

iTWire Wednesday, 20 September 2023 13:40 Zscaler Partners with Imprivata and CrowdStrike on new Zero Trust Security Solution for Healthcare Organisations 0 Dhawal Sharma, Zscaler Senior Vice President and General Manager Cloud security company Zscaler has teamed up with CrowdStrike and Imprivata to deliver a zero trust cybersecurity solution from device to cloud that’s custom-made for medical institutions. Zscaler says the new integration with the Imprivata Digital Identity Platform will provide visibility, threat protection and traceability for end-to-end, multi-user, shared device access control that are required for organisations to meet regulatory requirements, including HIPAA and HITECH. Through the new Zscaler integration with Imprivata, Zscaler is able to take Imprivata context and leverage the existing integration with CrowdStrike Falcon® Zero Trust Assessment (ZTA) score to control access to applications with adaptive, risk-based policies. According to Zscaler, as ransomware targeting healthcare organisations increases, more advan advanced cybersecurity is needed to protect sensitive patient data and maintain uninterrupted operations for the continuous delivery of life-critical medical services - and with this new integration, users of the Zscaler Zero Trust Exchange® platform, Imprivata OneSign®, and the CrowdStrike Falcon® platform will be able to more effectively adopt a zero trust architecture that offers granular access management, threat protection, and traceability capabilities to better protect against ransomware. Zscaler says hospitals and healthcare organisations face a unique security and identity challenge - and with shared workstations among staff, they must determine how they can distinguish who is doing what on which device and enforce access control policies and threat protections based on both the user who logged in at the time and the device's posture. They also need to keep track of all user activity with logs indicating their actions for traceability and compliance requirements “Cyberattacks on healthcare organisations are at an all-time high, and protecting patient data is critical to maintaining trust,” said Dhawal Sharma, Senior Vice President and General Manager at Zscaler. “Zscaler’s integrations with Imprivata, in addition to CrowdStrike, provide much needed help to healthcare organisations in their journey to a zero trust architecture. We’re aiding workers and technicians with least privileged access to the healthcare information they need to provide care and maintain the privacy and security of patient data.” Customer and Partner Quotes “We require a HIPAA-compliant zero trust solution that provides secure access to patient data. Enhanced vendor interoperability will significantly enhance our operational efficiency when it comes to defending against and responding to cyberattacks,” said Keith Duemling, Sr. Director of Cybersecurity Technology Protection at Cleveland Clinic. “We are delighted to see Zscaler integrating with Imprivata and CrowdStrike to address our needs, and bolstering our ability to defend against ransomware and other advanced cyberattacks." “Simplifying secure access to healthcare data is key to improving clinician productivity," said Mark McArdle, Chief Product & Design Officer at Imprivata. "This partnership with Zscaler strengthens our zero trust ecosystem, and ultimately advances outcomes for both patients and clinicians.” “Our joint efforts will ensure patient data remains confidential, integrity is upheld, and critical services are always available,” said Raj Rajamani, Chief Product Officer of CrowdStrike. “The Falcon platform's ability to swiftly identify and thwart sophisticated ransomware attacks on devices and in the cloud, combined with Zscaler's device posture-driven access control offers comprehensive end-to-end Zero Trust solution for healthcare organizations and significantly reduces the risk of breach and data exfiltration.” Zscaler integration with the Imprivata Digital Identity Platform Highlights: Multi-user, shared workstation policy enforcement and threat protection for healthcare environments End-to-end, Zero Trust Security enabling role-based access control to protect patient data Traceability of user actions on a multi-user, shared workstation for regulatory compliance including HIPAA and HITECH Zscaler and CrowdStrike say they partner to simplify the adoption of zero trust for IT teams by providing an integrated end-to-end security solution. Read 15 times It's all about Webinars. Marketing budgets are now focused on Webinars combined with Lead Generation. If you wish to promote a Webinar we recommend at least a 3 to 4 week campaign prior to your event. The iTWire campaign will include extensive adverts on our News Site itwire.com and prominent Newsletter promotion https://itwire.com/itwire-update.html and Promotional News & Editorial. Plus a video interview of the key speaker on iTWire TV https://www.youtube.com/c/iTWireTV/videos which will be used in Promotional Posts on the iTWire Home Page. Now we are coming out of Lockdown iTWire will be focussed to assisting with your webinars and campaigns and assistance via part payments and extended terms, a Webinar Business Booster Pack and other supportive programs. We can also create your adverts and written content plus coordinate your video interview. We look forward to discussing your campaign goals with you. Please click the button below.

Imprivata Frequently Asked Questions (FAQ)

  • When was Imprivata founded?

    Imprivata was founded in 2002.

  • Where is Imprivata's headquarters?

    Imprivata's headquarters is located at 20 CityPoint, 6th floor, Waltham.

  • What is Imprivata's latest funding round?

    Imprivata's latest funding round is Take Private.

  • How much did Imprivata raise?

    Imprivata raised a total of $28.41M.

  • Who are the investors of Imprivata?

    Investors of Imprivata include Thoma Bravo, Highland Capital Partners, General Catalyst, Polaris Partners, Sapphire Ventures and 3 more.

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.